Health Care: Drugs

Dynavax Technologies Corp (DVAX: NASDAQ)

$1.435 0.025 | 1.77%
08/22/14 - 01:21 PM ET
Company Profile
Price and Volume
Recent Price 1.41
52 Week High 2.14
52 Week Low 1.10
Avg. Daily Vol. (Mil) 1.81
Beta (3 year) 3.76
Share Related Items
Mkt Cap (Mil) 370.66
Shares Out (Mil) 262.88
Float (Mil) 222.45
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 7.70
Current Ratio 8.00
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 30.09
Price/Book 2.46
Price/Cash Flow -5.00
Per Share Data
Earnings -0.32
Sales 0.05
Book Value 0.57
Cash Flow -0.28
Business Summary
Dynavax Technologies Corp is a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases.
General Information
2929 Seventh Street
Suite 100
Berkeley, CA 94710-2753
www.dynavax.com
Industry : Drugs
Sector: Health Care
Employees: 151
CEO: Eddie Gray
Short Interest
Current Month (Mil) 27.60
Previous Month (Mil) 27.63
Short Interest Ratio (Days) 13.40
Management Effectiveness
Return on Equity n.a.
Return on Assets -38.80
Return on Investments -44.70
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with DVAX

Latest DVAX Headlines from TheStreet

More Financial News for DVAX

Press Releases for DVAX

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter